
Personalized care is key to managing hyperhidrosis, blending therapies, addressing adverse effects, and empowering patients with tailored solutions.

Personalized care is key to managing hyperhidrosis, blending therapies, addressing adverse effects, and empowering patients with tailored solutions.

Adam Friedman, MD, FAAD, takes a closer look at the emerging landscape of oral treatments for hyperhidrosis and what lies ahead in advancing patient care.

In addition to recapping key highlights from his session, Friedman discusses what is new or upcoming in dermatology that most excites him.

Grant applications are open from now until August 24, 2023, with an anticipated project start/end date of January 2024 through July 2025.